Chlorophyll
10 benefits mapped to clinical evidence across supplements.
Dose per serving from products
851 products in our catalogue print how much Chlorophyll a serving holds.
Most common: 25 mg to 50 mg, 30% of 851 products.
| Dose per serving | Products |
|---|---|
| 500 mcg or less | 41 |
| 500 mcg to 1 mg | 12 |
| 1 mg to 2.5 mg | 11 |
| 2.5 mg to 5 mg | 46 |
| 5 mg to 10 mg | 103 |
| 10 mg to 25 mg | 126 |
| 25 mg to 50 mg | 254 |
| 50 mg to 100 mg | 172 |
| 100 mg to 250 mg | 44 |
| over 250 mg | 42 |
Benefit Evidence
Leukopenia response +85%
Cervical/fertility recovery improved
Rosacea relapse lower
Leukopenia response +85%
Cervical/fertility recovery improved
Rosacea relapse lower
Research sources
Illness recovery (3)
- Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia
PubMed ID: 16417778
Chlorophyllin improved leukocyte counts in leukopenic patients—consistent with faster hematologic recovery.
- Comparative study of treatment efficacy in severe intraepithelial squamous cell lesions and preinvasive cervical cancer by conization and chlorin e6-mediated fluorescence-assisted systemic photodynamic therapy
PubMed ID: 38521149
Showed higher normalization rates and better reproductive outcomes versus conization, indicating faster/better clinical recovery.
- A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
PubMed ID: 39788468
Produced strong lesion reduction and fewer relapses than comparator, implying more durable/speedy clinical improvement.
Immune support (2)
- Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia
PubMed ID: 16417778
Randomized study: sodium copper chlorophyllin associated with marked improvement in leukopenia (85% response), direct immune‑related outcome.
- Efficacy of chlorophyll c2 for seasonal allergic rhinitis: single-center double-blind randomized control trial
PubMed ID: 27277115
Chlorophyll c2 reduced rescue medication use for seasonal allergic rhinitis (8‑week RCT), suggesting modulation of allergic immune responses.
Antioxidant (1)
- Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer
PubMed ID: 11724948
Chlorophyllin reduced aflatoxin‑DNA adducts (~55%), consistent with reducing oxidative/damage biomarkers.
Detoxification (1)
- Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer
PubMed ID: 11724948
Large randomized trial: chlorophyllin tablets decreased urinary aflatoxin‑N7‑guanine adducts by ~55%—strong evidence for binding/sequestration of a dietary toxin.
Acne (1)
- A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
PubMed ID: 39788468
Direct rosacea trial showing ~82% lesion-count reduction and fewer relapses—strong evidence for clearer skin.
Inflammation (1)
- A Chlorin e6 derivative-mediated photodynamic therapy versus doxycycline for moderate-to-severe rosacea: A prospective, randomized, controlled study
PubMed ID: 39788468
Rosacea is inflammatory; large lesion-count reductions and fewer relapses indicate meaningful anti-inflammatory/clinical effect.
Hormone balance (1)
- Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women
PubMed ID: 24993695
Green‑plant membrane supplement increased GLP‑1 (a metabolic hormone) in tests—direct hormone‑related effect in humans.
Metabolism (1)
- Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women
PubMed ID: 24993695
12‑week green‑plant membrane supplement gave greater weight loss and improved lipids—indirect evidence of metabolic benefit.
Weight management (1)
- Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women
PubMed ID: 24993695
12‑week randomized supplement produced greater weight loss vs placebo (clinically meaningful effect).
Wellbeing (1)
- Body weight loss, reduced urge for palatable food and increased release of GLP-1 through daily supplementation with green-plant membranes for three months in overweight women
PubMed ID: 24993695
12‑week supplement improved weight loss and lipid markers—signals a measurable wellness benefit.
Similar by evidence
Supplements the same benefits carry qualifying findings for — a fact about the evidence graph, not a recommendation to swap.
Products with Chlorophyll
Search all1300 products whose verified label declares Chlorophyll — not every bottle that mentions it in a title.